← Back to headlines
Apogee Secures $1.3B Financing from Blackstone for Zumilokibart Advancement
Apogee (APGE) has successfully secured up to $1.3 billion in non-dilutive financing from Blackstone to further the development of its drug candidate, Zumilokibart.
5 Jun, 12:55 — 5 Jun, 12:55
Sources
Showing 1 of 1 sources
Related Stories
Lionel Richie Hospitalized in ICU Following St. Louis Concert
48m ago
Anna Hazare admitted to Mumbai hospital's ICU with acute dehydration, kidney issue
4h ago
Ebola Outbreak in Democratic Republic of Congo Surpasses 6,000 Cases
6h ago
England Pharmacies to Offer Free Quick Cholesterol Screening Tests
14h ago